Skip to Content

93 1025 (Nefazodone Hydrochloride 200 mg)

Pill with imprint 93 1025 is Yellow, Capsule-shape and has been identified as Nefazodone Hydrochloride 200 mg. It is supplied by Teva Pharmaceuticals USA.

Nefazodone is used in the treatment of depression; major depressive disorder and belongs to the drug class phenylpiperazine antidepressants. Risk cannot be ruled out during pregnancy. Nefazodone 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 1025

Nefazodone hydrochloride 200 mg 93 1025 Front
Nefazodone hydrochloride 200 mg 93 1025 Back
Nefazodone hydrochloride 200 mg 93 1025
Nefazodone hydrochloride 200 mg 93 1025

Nefazodone Hydrochloride

Imprint
93 1025
Strength
200 mg
Color
Yellow
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Phenylpiperazine antidepressants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-1025
Inactive Ingredients
silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, povidone k30, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.